Using Video Images to Improve Advance Care Planning in Patients With Cancer

Massachusetts General Hospital1 site in 1 country80 target enrollmentAugust 2009

Overview

Brief Summary

The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone.

Detailed Description

The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone. Subjects will choose among three goals of care, life prolonging care, basic medical care, and comfort care.

Registry

clinicaltrials.gov

Start Date

August 2009

End Date

June 2011

Last Updated

14 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Massachusetts General Hospital

Responsible Party

Principal Investigator

Angelo E. Volandes, MD

Faculty

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

•Terminal, progressive cancer with poor prognosis whose treatment intent is palliative, based on the following definition:
•All patients with brain cancer, liver cancer, inoperable non-small cell lung carcinoma, pancreatic cancer, or gallbladder cancer; OR
•Patients with the following cancers: metastatic colon cancer or stage III or IV non-small cell lung cancer; OR
•Patients with the following cancers, if first-line therapy has failed and limited response is expected to second-line therapy: breast cancer, colorectal cancer, head and neck cancer, stomach cancer, esophageal cancer, melanoma, leukemia, ovarian cancer, prostate cancer, renal cancer, sarcoma, lung cancer, myeloma, or lymphoma.
•The terms terminal, progressive, poor prognosis, palliative intent and limited response will be judged by the patient's oncologist (and not by the RSA or consenting professional).
•Return patient visit (defined as a patient known to the oncologist from previous assessments and treatments, where the working and personal relationship has been established and not a new patient to the clinic).
•English speaking. Only English-speaking patients will be included in our present study since English is the validated language of our study tools.
•Given the sensitive nature of the study, clinicians will decide whether the patient is a potentially appropriate subject based on their knowledge of the patient.
•Able to provide informed consent.
•Age greater than or equal to 21.